Satoshi Shigeno
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 16, 2026
Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy.
Journal: Hepatology communications
Published: October 31, 2025
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 16, 2025
First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 11, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 06, 2025
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 20, 2024
Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis B.
Journal: Cellular and molecular gastroenterology and hepatology
Published: November 21, 2023
Genome-wide loss-of-function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus-integrated hepatoma cells.
Journal: Cancer science
Published: October 09, 2023
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 27, 2023
Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.
Journal: Hepatology communications
Published: February 16, 2022
TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
Journal: Hepatology (Baltimore, Md.)
Published: September 23, 2021
Last Updated: 09/26/2026